ARCHIVES

Ronald DePinho Apologizes, Takes Responsibility For “Morale Issues” at MD Anderson

This article is from The Cancer Letter archive.

Vol. 39 No. 36 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976

New Jersey Commission Calls For Major Hike In Cancer Spending

September 25, 1987

Five Group Chairs Discuss Mergers In A Q&A

March 11, 2011

“Action Steps” Listed For Prostate Research In National Blueprint

January 16, 1998